Skip to content

Remopharma

Active Private limited companyfounded 2008active for 18 yearsMeerdonkdorp 24, 9170 Sint-Gillis-WaasKBO/BCE: BE 0806.560.542 #8 company by equity in Sint-Gillis-Waas, Wholesale and retail trade sector

Annual accounts 2025

abbreviated format, filed on 18-08-2026, 18 days late
€1.1m
▲ 14.2%
€416,371
▼ 5.8%
€241,142
▼ 18.4%
€690,255
▼ 17.2%
60.2%
▲ 0.9 percentage points
1.83
▼ 0.49

Turnover and EBIT margin are not published. The abbreviated format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €3.0m. Estimated: probably between €2.2m and €4.1m.

Balance sheet

balance sheet total €3.7m on 31-12-2025
What the company ownsHow it is paid for

in €m

in euro

Position in the sector

60.2%

Higher than 74% of 13,289 companies in 2025.

1.83

Higher than 59% of 13,148 companies in 2025.

6.6%

Higher than 60% of 13,209 companies in 2025.

Remopharma Middle half of the sector 80% of the sector Abbreviated accounts in retail trade (NACE 47)

Net result: top quarter · Equity: top quarter · Balance sheet total: top quarter · Working capital: top quarter · Staff: middle half

Staff

€65,124

Staff costs divided by the average number of full-time equivalents.

level

employees who joined employees who left

In 2025, 2 employees joined and 2 left.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023200916 months
Balance sheet: assets
20/58 3.7m3.3m3.3m767,116
21/28 2.1m1.8m1.9m488,715
21 122,779148,179173,579208,000
22/27 2.0m1.7m1.7m280,715
22 1.2m1.1m1.2m196,296
23 843,549553,225488,769477
24 16,56218,25211,38083,942
29/58 1.5m1.5m1.4m278,401
3 507,696497,991464,97882,009
30/36 507,696497,991464,97882,009
40/41 333,208255,574277,14642,275
40 300,944220,225235,70839,468
41 32,26435,35041,4382,806
50/53 426,222501,222376,222-
54/58 233,124194,009252,574152,593
490/1 17,71814,74513,4871,525
Balance sheet: equity and liabilities
10/49 3.7m3.3m3.3m767,116
10/15 2.2m2.0m1.7m137,968
10/11 1,0001,0001,000116,000
100 ---116,000
13 2.2m2.0m1.7m21,968
130/1 --0-
130 ---11,600
1311 --0-
132 118118118-
133 2.2m2.0m1.7m10,368
17/49 1.5m1.3m1.6m629,148
17 629,311716,145831,724440,646
170/4 629,311716,145831,724440,646
42/48 827,712629,551747,208187,657
42 124,793132,755149,91336,080
44 628,904447,431499,07777,346
440/4 628,904447,431499,07777,346
45 73,89149,28098,0636,040
450/3 18,13811,00361,1056,040
454/9 55,75338,27736,958-
47/48 1258515568,191
492/3 1,2501,8323,452845
Income statement
9900 1.1m965,347932,226161,901
62 455,871329,855303,705-
630 205,996179,294160,54878,773
640/8 24,01114,26611,97430,363
9901 416,371441,932455,99952,766
75/76B 11,59614,5556,44131
75 11,59614,5556,44131
65/66B 112,54161,76861,16624,783
65 112,54161,76861,16624,783
9903 315,427394,719401,27428,013
67/77 74,28599,12497,1546,045
9904 241,142295,595304,12021,968
9905 241,142295,595304,12021,968
Appropriation of the result
9906 241,142295,595304,12021,968
691/2 241,142295,595304,12021,968
6920 ---11,600
6921 241,142295,595304,12010,368
Social balance sheet
9087 76.15.3-
Hours worked1013 12,2099,5289,221-
Document PDFPDFPDFPDF

The notes to these accounts have 24 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 18-08-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

2025 annual accounts filed 18 days after the deadline. Filed on 18 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00403475.

Financial year Type Filed Reference Document
31-12-2025 abbreviated format 18-08-2026 2026-00403475 PDF
31-12-2024 abbreviated format 28-08-2025 2025-00457910 PDF
31-12-2023 abbreviated format 28-08-2024 2024-00422752 PDF
31-12-2009 abbreviated format 07-07-2010 2010-29200530 PDF

Subsidies and aid

Flemish government 2024 to 2025, 2 entries, €3,340 awarded, €3,340 paid

Year Entries AwardedPaid
2025 1 €2,531€2,531
2024 1 €809€809

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023200916 months
622,368621,226616,547131,539
447,138474,889464,668100,741
503,456160,898157,581567,488
39,114-58,564--
690,255833,990637,19890,744
60.2%59.3%51.3%18.0%
1.832.321.851.48
1.221.531.231.05
0.660.690.954.56
10.9%15.1%18.2%15.9%
6.6%8.9%9.4%2.9%
5.5310.0610.08-

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Social balance sheet

Item31-12-202531-12-202431-12-2023
Employees at the balance-sheet date997
full-time443
part-time554
in full-time equivalents76.85.8
76.15.3
On a permanent contract886
Joined264
Left244

Source: social balance sheet in the 2023 to 2025 annual accounts

Securities and guarantees

on own assets and for others
Item202520242023
Debts guaranteed by Belgian public bodies€754,104--

Source: notes to the 2023 to 2025 annual accounts (statement of debts and off-balance-sheet rights and commitments)

Investments

fixed assets acquired
Item202520242023
Tangible fixed assets€503,456€160,898€157,581
Financial fixed assets€0--
€205,996€179,294€160,548

Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)

Insights on Remopharma

The operating result for 2025 is 6% lower than in 2024 and the lowest since 2009. It is the second fall in a row.

Debt's share of the balance-sheet total falls from 40.7% to 39.8%. Equity and debt are higher.

Next steps